These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18026883)

  • 61. [Development, situation and perspective of self-help support in Germany].
    Geene R; Huber E; Hundertmark-Mayser J; Möller-Bock B; Thiel W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jan; 52(1):11-20. PubMed ID: 19189150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Innovative work behavior in healthcare: the benefit of operational guidelines in the treatment of rare diseases.
    Kessel M; Hannemann-Weber H; Kratzer J
    Health Policy; 2012 May; 105(2-3):146-53. PubMed ID: 22405486
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Networking for rare diseases: a necessity for Europe.
    Aymé S; Schmidtke J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1477-83. PubMed ID: 18026888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Major importance of independent clinical research for the evaluation of new treatment modalities].
    Hallek M
    Dtsch Med Wochenschr; 2013 Feb; 138(5):167. PubMed ID: 23340931
    [No Abstract]   [Full Text] [Related]  

  • 66. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Care for patients with rare diseases].
    Smetsers SE; Takkenberg JJ; Bierings MB
    Ned Tijdschr Geneeskd; 2014; 158():A7960. PubMed ID: 25336312
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas].
    Eich HT; Schneeweiss A; Skripnitchenko R; Hansemann K; Gossmann A; Müller RP
    Rontgenpraxis; 2007; 56(4):145-51. PubMed ID: 17390954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Introduction of the electronic health card in Germany: influence of interest positions and sector membership on the establishment of an implementation network].
    Lang A; Mertes A
    Gesundheitswesen; 2011 Jan; 73(1):e12-20. PubMed ID: 20169528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Rare diseases--a problem of healthcare-related social security law].
    Rixen S
    Z Evid Fortbild Qual Gesundhwes; 2008; 102(1):31-6. PubMed ID: 19009939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data.
    Groft SC; de la Paz MP
    Adv Exp Med Biol; 2010; 686():3-14. PubMed ID: 20824436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Networks of National Reference Centers and associated Consiliary Laboratories in Germany].
    Laude G; Kist M; Krause G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Feb; 55(2):223-30. PubMed ID: 22290166
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Early recognition and intervention for bipolar disorders: state of research and perspectives].
    Pfennig A; Correll CU; Leopold K; Juckel G; Bauer M
    Nervenarzt; 2012 Jul; 83(7):897-902. PubMed ID: 22733382
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Integrated Center for Research and Treatment of Vertigo, Balance and Ocular Motor Disorders].
    Brandt T; Zwergal A; Jahn K; Strupp M
    Nervenarzt; 2009 Aug; 80(8):875-86. PubMed ID: 19662450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Rare diseases, digitization, and the National Action League for People with Rare Diseases (NAMSE)].
    Wessel T; Heuing K; Schlangen M; Schnieders B; Algermissen M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1119-1125. PubMed ID: 36239769
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Not Available].
    Aymé S
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():12-3. PubMed ID: 27137855
    [No Abstract]   [Full Text] [Related]  

  • 77. [Inaugural conference - what stakes face rare diseases in the French health care system].
    Péton-Klein D
    Med Sci (Paris); 2014 Apr; 30 Spe(1):5-7. PubMed ID: 24755170
    [No Abstract]   [Full Text] [Related]  

  • 78. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges.
    Weleber RG
    Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344
    [No Abstract]   [Full Text] [Related]  

  • 79. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Community-based rehabilitation and outpatient care for patients with acquired brain injury and chronic neurological disability in Germany: continuing support for social participation and re-integration in the neurological care system?].
    Reuther P; Hendrich A; Kringler W; Vespo E
    Rehabilitation (Stuttg); 2012 Dec; 51(6):424-30. PubMed ID: 23235935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.